Eye-drop maker recalls CVS, Target, Walmart-branded products
By Eleanor Laise
Recall triggered by insanitary conditions found by FDA investigators
The manufacturer of eye drops sold under CVS Health Corp. (CVS), Target Corp. (TGT), Rite Aid Corp. (RADCQ), Walmart Inc. (WMT) and other brands has recalled 27 products that were the subject of recent U.S. Food and Drug Administration warnings about potential contamination.
Kilitch Healthcare India Ltd., a pharmaceutical company based in Mumbai, is voluntarily recalling the products labeled with the brands of the major retailers as well as Cardinal Health Inc.'s (CAH) Rugby and Leader labels, according to an announcement posted Wednesday on the FDA's site.
The products are being recalled due to potential safety concerns after FDA investigators found insanitary conditions, the statement said. The recall includes all lots with expiration dates ranging from November 2023 to September 2025. The products were distributed nationwide to retailers and wholesalers and via the product distributor Velocity Pharma LLC.
The FDA warned consumers in late October not to buy or use the products, saying they pose a risk of eye infections that could cause partial vision loss or blindness. The retailers pulled affected products from their shelves.
Kilitch has not received any reports of adverse events related to the recall, according to the statement posted Wednesday.
The recall comes on the heels of an FDA warning to Amazon.com Inc. (AMZN) about the sale of unapproved eye drops marketed for treatment of redness, pink eye and other conditions. The agency warned CVS and Walgreens Boots Alliance Inc. (WBA) about similar issues in September.
A string of eye-product safety issues has emerged this year amid increased federal scrutiny of eye-drop manufacturing. Several other eye-drop brands were also the subject of recalls earlier this year due to concerns about dangerous infections.
-Eleanor Laise
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-16-23 1154ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now